EBS logo

Emergent BioSolutions Inc. (EBS)

Profile

Full Name

Emergent BioSolutions Inc.

Ticker

NYSE: EBS

Exchange

NYSE

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

November 15, 2006

Indexes

Not included

Website

https://www.emergentbiosolutions.com

Employees

900

Key Details

Price

$12.48(-2.80%)

Market Cap

$655.45M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.04B(-0.54% YoY)

Annual EPS

-$3.60(75.79% YoY)

PE Ratio

9.64

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $12.48
    EBS price is $12.48

    30-Day Relative Volume

    1.99
    EBS 30-day relative volume is 1.99

    Price Performance

    Price Most Recent Change

    -2.8%
    EBS price was down -2.8% on Oct 31, 2025

    Price YTD Change

    +30.54%
    EBS price is up +30.54% since January 1st

    Price 1-Year Change

    +37.75%
    EBS price is up +37.75% year-on-year

    Price 3-Year Change

    -40.17%
    EBS price is down -40.17% over the past 3 years

    Price Range

    Price All-Time High

    $137.61
    EBS price is currently -90.93% below its historical high of $137.61

    Price 3-Year Low

    $1.42
    EBS price is currently +778.87% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $655.45M
    EBS market cap is $655.45 million

    Market Cap 3-Year Change

    -37.03%
    EBS market cap is down -37.03% over the past 3 years

    Market Cap All-Time High

    $7.14B
    EBS market cap is currently -90.82% below its historical high of $7.14 billion

    Market Cap Sector Percentile

    65.22%
    EBS market cap is higher than 65.22% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -3.07%
    EBS shares outstanding is down -3.07% year-on-year

    Shares Outstanding 3-Year Change

    +5.25%
    EBS shares outstanding is up +5.25% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.57
    EBS beta is 1.57

    200-day SMA

    $7.42
    EBS price is currently +68.20% above its 200-day simple moving average

    50-day SMA

    $8.96
    EBS price is currently +39.35% above its 50-day simple moving average

    14-Day RSI

    73.71
    EBS 14-day relative strength index is 73.71

    Volume

    1.99
    EBS 30-day relative volume is 1.99

    ATR

    $0.77
    EBS average true range is $0.77

    10-day Historical Volatility

    190.29%
    EBS 10-day historical volatility is 190.29%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.04B
    EBS annual revenue is $1.04 billion

    Revenue Analysts Estimate

    $809.40M
    EBS annual revenue is currently +28.94% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    -0.54%
    EBS annual revenue is down -0.54% year-on-year

    Revenue Sector Percentile

    85.71%
    EBS annual revenue is higher than 85.71% of companies in Healthcare sector

    EPS

    EPS

    -$3.60
    EBS annual earnings per share is -$3.60

    EPS Analysts Estimate

    $1.26
    EBS annual earnings per share is currently -384.78% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +75.79%
    EBS annual earnings per share is up +75.79% year-on-year

    EPS Sector Percentile

    26.57%
    EBS annual earnings per share is higher than 26.57% of companies in Healthcare sector

    Profit

    Gross Profit

    $305.20M
    EBS annual gross profit is $305.20 million

    Gross Margin

    29.24%
    EBS annual gross profit margin is 29.24%

    Operating Profit

    -$81.50M
    EBS annual operating income is -$81.50 million

    Operating Margin

    -5.60%
    EBS annual operating profit margin is -5.60%

    Net Income

    -$190.60M
    EBS annual net profit is -$190.60 million

    Net Margin

    -18.80%
    EBS annual net profit margin is -18.80%

    Expenses

    Total Expenses

    $1.23B
    EBS annual total expenses is $1.23 billion

    Operating Expenses

    $363.60M
    EBS annual total operating expenses is $363.60 million

    Cost Of Goods Sold

    $738.40M
    EBS annual cost of goods sold is $738.40 million

    Selling, General & Administrative Expenses

    $308.00M
    EBS annual SG&A is $308.00 million

    Depreciation & Amortization

    $108.80M
    EBS annual D&A is $108.80 million

    Interest Expense

    $0.00
    EBS annual interest expense is $0.00

    Income Tax

    $47.70M
    EBS annual income tax is $47.70 million

    EBIT & EBITDA

    EBIT

    -$71.90M
    EBS annual earnings before interest & taxes is -$71.90 million

    EBITDA

    $36.90M
    EBS annual EBITDA is $36.90 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $1.40B
    EBS annual total assets is $1.40 billion

    Non Current Assets

    $791.00M
    EBS annual long term assets is $791.00 million

    Current Assets

    $598.70M
    EBS annual total current assets is $598.70 million

    Cash and Cash Equivalents

    $105.60M
    EBS annual cash & cash equivalents is $105.60 million

    Accounts Receivable

    $154.50M
    EBS annual accounts receivable is $154.50 million

    Inventory

    $311.70M
    EBS annual inventory is $311.70 million

    Liabilities

    Total Liabilities

    $914.10M
    EBS annual total liabilities is $914.10 million

    Long Term Liabilities

    $78.30M
    EBS annual total long term liabilities is $78.30 million

    Current Liabilities

    $162.40M
    EBS annual current liabilities is $162.40 million

    Accounts Payable

    $60.90M
    EBS annual accounts payable is $60.90 million

    Debt

    Total Debt

    $676.10M
    EBS annual total debt is $676.10 million

    Total Debt 1-Year Change

    -22.95%
    EBS annual total debt is down -22.95% year-on-year

    Long Term Debt

    $673.40M
    EBS annual long term debt is $673.40 million

    Short Term Debt

    $2.70M
    EBS annual short term debt is $2.70 million

    Equity & Capital

    Shareholders Equity

    $482.80M
    EBS annual stockholders equity is $482.80 million

    Book Value

    $482.80M
    EBS annual book value is $482.80 million

    Retained Earnings

    -$212.40M
    EBS annual retained earnings is -$212.40 million

    Working Capital

    $436.30M
    EBS annual working capital is $436.30 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $58.70M
    EBS annual cash from operations is $58.70 million

    Cash From Operations 1-Year Change

    +128.45%
    EBS annual cash from operations is up +128.45% year-on-year

    Cash From Investing

    $125.20M
    EBS annual cash from investing is $125.20 million

    Cash From Investing 1-Year Change

    -41.03%
    EBS annual cash from investing is down -41.03% year-on-year

    Cash From Financing

    -$190.00M
    EBS annual cash from financing is -$190.00 million

    Cash From Financing 1-Year Change

    +64.53%
    EBS annual cash from financing is up +64.53% year-on-year

    CAPEX

    CAPEX

    $22.90M
    EBS annual capital expenditures is $22.90 million

    CAPEX 1-Year Change

    -55.62%
    EBS annual capital expenditures is down -55.62% year-on-year

    Free Cash Flow

    Free Cash Flow

    $35.80M
    EBS annual free cash flow is $35.80 million

    Free Cash Flow 1-Year Change

    +113.88%
    EBS annual free cash flow is up +113.88% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    29.24%
    EBS annual gross profit margin is 29.24%

    Operating Margin

    -5.60%
    EBS annual operating profit margin is -5.60%

    Net Margin

    -18.80%
    EBS annual net profit margin is -18.80%

    ROA & ROE

    ROA

    -11.80%
    EBS annual return on assets is -11.80%

    ROE

    -33.67%
    EBS annual return on equity is -33.67%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    9.64
    EBS price to earnings ratio is 9.64

    PE Ratio Sector Percentile

    13.55%
    EBS price to earnings ratio is higher than 13.55% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    1.13
    EBS price to book ratio is 1.13

    PB Ratio Sector Percentile

    36.05%
    EBS price to book ratio is higher than 36.05% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.83
    EBS price to sales ratio is 0.83

    PS Ratio Sector Percentile

    17.74%
    EBS price to sales ratio is higher than 17.74% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.08B
    EBS enterprise value is $1.08 billion

    Enterprise Value Sector Percentile

    72.97%
    EBS enterprise value is higher than 72.97% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    4.99
    EBS EV/EBITDA is 4.99

    EV/EBITDA Sector Percentile

    77.74%
    EBS EV/EBITDA is higher than 77.74% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.69
    EBS annual current ratio is 3.69

    Quick Ratio

    1.77
    EBS annual quick ratio is 1.77

    Leverage

    Debt To Equity

    1.40
    EBS annual debt to equity ratio is 1.40

    Interest Coverage Ratio

    -
    EBS annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    7
    EBS piotroski f-score is 7

    Altman Z-Score

    1.17
    EBS altman z-score is 1.17

    Analyst ratings

    Recent major analysts updates

    Sep 3, 25 HC Wainwright & Co.
    Buy
    Apr 1, 25 HC Wainwright & Co.
    Buy
    Mar 21, 25 HC Wainwright & Co.
    Buy
    Mar 4, 25 HC Wainwright & Co.
    Buy
    Jan 21, 25 HC Wainwright & Co.
    Buy
    Jan 10, 25 HC Wainwright & Co.
    Buy
    Dec 30, 24 HC Wainwright & Co.
    Buy
    Nov 7, 24 Benchmark
    Buy
    Sep 13, 24 Rodman & Renshaw
    Buy
    Aug 22, 24 Rodman & Renshaw
    Buy

    Institutional Ownership

    Screeners with EBS included

    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Stocks with high RSI
    • What is the ticker symbol for Emergent BioSolutions Inc.?
    • Does Emergent BioSolutions Inc. pay dividends?
    • What sector is Emergent BioSolutions Inc. in?
    • What industry is Emergent BioSolutions Inc. in?
    • What country is Emergent BioSolutions Inc. based in?
    • When did Emergent BioSolutions Inc. go public?
    • Is Emergent BioSolutions Inc. in the S&P 500?
    • Is Emergent BioSolutions Inc. in the NASDAQ 100?
    • Is Emergent BioSolutions Inc. in the Dow Jones?
    • When was Emergent BioSolutions Inc.'s last earnings report?
    • When does Emergent BioSolutions Inc. report earnings?

    What is the ticker symbol for Emergent BioSolutions Inc.?

    The ticker symbol for Emergent BioSolutions Inc. is NYSE:EBS

    Does Emergent BioSolutions Inc. pay dividends?

    No, Emergent BioSolutions Inc. does not pay dividends

    What sector is Emergent BioSolutions Inc. in?

    Emergent BioSolutions Inc. is in the Healthcare sector

    What industry is Emergent BioSolutions Inc. in?

    Emergent BioSolutions Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Emergent BioSolutions Inc. based in?

    Emergent BioSolutions Inc. is headquartered in United States

    When did Emergent BioSolutions Inc. go public?

    Emergent BioSolutions Inc.'s initial public offering (IPO) was on November 15, 2006

    Is Emergent BioSolutions Inc. in the S&P 500?

    No, Emergent BioSolutions Inc. is not included in the S&P 500 index

    Is Emergent BioSolutions Inc. in the NASDAQ 100?

    No, Emergent BioSolutions Inc. is not included in the NASDAQ 100 index

    Is Emergent BioSolutions Inc. in the Dow Jones?

    No, Emergent BioSolutions Inc. is not included in the Dow Jones index

    When was Emergent BioSolutions Inc.'s last earnings report?

    Emergent BioSolutions Inc.'s most recent earnings report was on October 29, 2025

    When does Emergent BioSolutions Inc. report earnings?

    The date for Emergent BioSolutions Inc.'s next earnings report has not been announced yet
    On this page